KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) Cost of Revenue (2016 - 2026)

Historic Cost of Revenue for Exelixis (EXEL) over the last 14 years, with Q1 2026 value amounting to $26.5 million.

  • Exelixis' Cost of Revenue rose 3263.71% to $26.5 million in Q1 2026 from the same period last year, while for Jan 2026 it was $83.7 million, marking a year-over-year increase of 981.55%. This contributed to the annual value of $83.7 million for FY2026, which is 981.55% up from last year.
  • Per Exelixis' latest filing, its Cost of Revenue stood at $26.5 million for Q1 2026, which was up 3263.71% from $18.6 million recorded in Q4 2025.
  • In the past 5 years, Exelixis' Cost of Revenue registered a high of $26.5 million during Q1 2026, and its lowest value of $13.2 million during Q2 2022.
  • In the last 5 years, Exelixis' Cost of Revenue had a median value of $18.1 million in 2023 and averaged $18.1 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 4848.76% in 2024, then tumbled by 980.43% in 2025.
  • Over the past 5 years, Exelixis' Cost of Revenue (Quarter) stood at $15.9 million in 2022, then soared by 36.64% to $21.8 million in 2023, then dropped by 20.34% to $17.3 million in 2024, then rose by 7.19% to $18.6 million in 2025, then surged by 42.57% to $26.5 million in 2026.
  • Its Cost of Revenue stands at $26.5 million for Q1 2026, versus $18.6 million for Q4 2025 and $19.5 million for Q3 2025.